Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-054499
Filing Date
2020-11-18
Accepted
2020-11-18 17:20:51
Documents
63
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sprb-10q_20200930.htm 10-Q 2256263
2 EX-31.1 sprb-ex311_74.htm EX-31.1 18908
3 EX-31.2 sprb-ex312_72.htm EX-31.2 17534
4 EX-32.1 sprb-ex321_73.htm EX-32.1 8432
5 EX-32.2 sprb-ex322_26.htm EX-32.2 9686
  Complete submission text file 0001564590-20-054499.txt   6472415

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sprb-20200930.xml EX-101.INS 1041617
7 XBRL TAXONOMY EXTENSION SCHEMA sprb-20200930.xsd EX-101.SCH 46814
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sprb-20200930_cal.xml EX-101.CAL 37149
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sprb-20200930_def.xml EX-101.DEF 191237
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sprb-20200930_lab.xml EX-101.LAB 365012
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sprb-20200930_pre.xml EX-101.PRE 302573
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39594 | Film No.: 201326030
SIC: 2834 Pharmaceutical Preparations